-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Celestica, Raises Price Target to $400

Benzinga·04/29/2026 19:27:43
Listen to the news
UBS analyst David Vogt maintains Celestica (NYSE:CLS) with a Neutral and raises the price target from $355 to $400.